Loading...
  • renal
  • Twenty-seven consecutive patients with synchronous renal cell carcinoma and urothelial carcinoma treated in two tertiary medical centers from March 2005 to December 2015 were retrospectively reviewed. (biomedcentral.com)
  • The natural history of renal functional decline in patients undergoing surveillance in the DISSRM registry. (jhu.edu)
  • In a phase Ib study, dual therapy with axitinib and pembrolizumab was well tolerated and demonstrated antitumor activity in treatment-naïve patients with advanced renal cell carcinoma. (renalandurologynews.com)
  • Immunotherapy with atezolizumab plus targeted therapy with bevacizumab improves progression-free survival better than sunitinib in patients with untreated metastatic renal cell carcinoma. (renalandurologynews.com)
  • Partial nephrectomy was associated with decreased odds of death versus radical nephrectomy among patients with cT1b but not cT2 renal cell carcinoma. (renalandurologynews.com)
  • outcomes
  • Due to the rarity of the disease and the limited reports in the literature, the treatment and outcomes of concurrent RCC and urothelial carcinoma are still uncertain, especially for patients with concurrent RCC and bladder tumor. (biomedcentral.com)
  • We are also using the outcomes of this trial to design early interventions to avoid complications and improve patient quality of life after the operation. (stanford.edu)
  • urologists
  • In 2012, BAUS took the decision to publish results for nephrectomy (removal of the kidney) because, although not all urologists undertake it, nephrectomy was routinely performed by 35% of the 800 Consultant Urological Surgeons practising in England at that time. (baus.org.uk)
  • Formerly known as University Urologists PLLC, our Louisville urologists combine leading edge patient care with the dedication to deliver the finest in customer service. (uoflphysicians.com)
  • Oncology
  • The clinical program in urologic oncology provides the fellow the necessary resources to learn and to experience a hands-on educational approach to the care of the urologic oncology patient. (virginiamason.org)
  • Diseases
  • Dr. Matlaga is an independently funded investigator, and presently is the Principal Investigator for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Urologic Diseases in America project. (jhmi.edu)